Stocks to Sell

Stocks can plunge for any number of reasons — investors may need to raise cash for large milestone purchases, or algorithms could be triggered by stop losses which create massive selloffs. Whatever the case, InvestorPlace’s journalists weed out the markets’ losers, keeping you informed of which stocks to cash out of before they come crashing down.

Beyond Meat Stock Is Vulnerable to an ‘Info War’

By InvestorPlace Research Staff
Demand for fake meat has soared during the pandemic, boosting Beyond Meat stock. However, consumer sentiment risks getting derailed once buyers consider the health implications of plant-based meat.

Lemonade Stock: Is It Time to Buy on the Analyst-Induced Selloff?

By Will Ashworth, InvestorPlace Contributor
A Goldman Sachs downgrade slowed Lemonade’s (NYSE:LMND) momentum. Down 22% in the past week, is it time to buy Lemonade stock on the dip?

American Airlines Stock May Not Go to Zero, but It Could Get Very Close

By Marie Brodbeck, InvestorPlace Contributor
Contrarians looking to pick up airline stocks should exclude AAL stock because the firm's buy case is thin and its cash-burn will become a huge problem if demand doesn't pick up.

Here’s Why You Should Sell Your Nikola Stock and Never Look Back Again

By Chris Lau, InvestorPlace Contributor
Nikola stock will keep draft lower, following Tesla’s lead, as investors realize the stock dilution will hurt for longer.

Wells Fargo Will Have Investors Waiting for a Return to Glory

By Todd Shriber, InvestorPlace Contributor
Wells Fargo stock is one of the more downtrodden banks and that's saying something. The near-term outlook is murky at best.

Virgin Galactic Remains a Risky Play

By Faizan Farooque, InvestorPlace Contributor
SPCE stock is trading at a premium valuation, despite substantial competition and a business model that's still fraught with unknowns.

2 Reasons Why American Airlines Stock Is One to Sell

By Josh Enomoto, InvestorPlace Contributor
With the headlines quiet in terms of positive news, and the transition to bad news likely, AAL stock seems too risky to think about.

Novavax Stock Needs Solid Results Beyond Headlines

By Chris Markoch, InvestorPlace Contributor
NVAX stock is one of the hottest biotech stocks in 2020. But it's time for the company to deliver results worthy of its price.

iBio Stock Is a Highly Speculative Covid-19 Play That Isn’t Worth It

By Luke Lango, InvestorPlace Senior Investment Analyst
Too much speculation, and too weak fundamentals, makes IBIO stock a sell today for risk-adverse, disciplined investors.

What Makes FuelCell Unique Is What Makes It a Risky Buy

By Chris Markoch, InvestorPlace Contributor
Hydrogen fuel cells (HFCs) are trendy as renewable energy moves to center stage. But is there enough demand for HFC power plants to make FCEL stock a buy?

MGM Stock Will Survive the Pandemic, but It Isn’t Going to Thrive

By Todd Shriber, InvestorPlace Contributor
On July 30, the Bellagio operator delivered second-quarter results that were more dismal than expected and that's saying something because with commercial casinos across the U.S shuttered large parts, or in some cases, all of the June quarter, the earnings bar is low for the gaming industry. MGM said it lost $1.67 a share on revenue of $289.81 million in the April through June period. Analysts expected a loss of $1.60 on turnover of $408.95 million.

Stay Far Away From ‘Sucker’s Bet’ Kodak Stock

By InvestorPlace Research Staff
The latest scheme to breathe life into Kodak stock won't end well for investors. Speculation will fizzle out, so avoid it completely.

How the Coronavirus and Competition Threaten Carnival

By Josh Enomoto, InvestorPlace Contributor
CCL stock was starting to look interesting. However, a cruise ship outbreak in Norway poses major challenges for the entire industry.

Roku Stock Has a TCL Problem. Shares May Sink 35%

By Thomas Yeung, CFA, InvestorPlace Markets Analyst
Roku stock stands to drop 35% after TCL Electronic's decision in June to drop Roku's exclusivity agreement. Investors should sell.

XpresSpa Isn’t Worth Investor Money Regardless of Its Core Business

By Alex Sirois, InvestorPlace Contributor
Right now, XSPA stock doesn't make sense under any scenario. Speculative investments continue, but nothing is redeeming XpresSpa long-term.

Long-Term Investors May Want to Keep Away from Ocugen

By Tezcan Gecgil, InvestorPlace Contributor
OCGN stock offers risky odds with a limited payoff structure. Stay away from Ocugen except for a speculative play.

Without a Covid-19 Vaccine, GERM Is a Much Safer Way to Play iBio Stock

By Will Ashworth, InvestorPlace Contributor
IBIO stock has more than double in price in recent weeks. Here’s why playing it safe makes sense.

FuelCell’s Threats Still Outweigh Its Potential

By Larry Ramer, InvestorPlace Contributor
The fiscal problems of states and the popularity of solar-battery combinations are poised to weigh on FCEL stock.

Please Don’t Be the Last One Holding the Bag for Genius Brands

By InvestorPlace Research Staff
Those who are bullish on GNUS stock certainly bark the loudest. But this kind of volume isn’t enough to sustain GNUS stock for the long run.
Load More Articles